Open access
Sep 2026
HSP90AA1 Knockdown Enhances Doxorubicin Sensitivity by Promoting Immunogenic Cell Death-Related Signaling and Immune-Related Tumor Microenvironment Remodeling in Breast Cancer
It is found that HSP90AA1 was highly expressed in breast cancer and was associated with unfavorable prognosis, and reducing HSP90AA1 expression enhanced the response to doxorubicin, increased apoptosis-related changes, and was accompanied by molecular changes associated with immunogenic cell death and the tumor immune...
Rui Chen, Yao Jin, Chang-Bin Xie et al.
· Cancers · 0 citations